IBDEI1KN ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27897,2)
 ;;=Urethritis, NOS^124214
 ;;^UTILITY(U,$J,358.3,27898,0)
 ;;=788.41^^162^1789^57
 ;;^UTILITY(U,$J,358.3,27898,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27898,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,27898,1,5,0)
 ;;=5^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,27898,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,27899,0)
 ;;=788.31^^162^1789^60
 ;;^UTILITY(U,$J,358.3,27899,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27899,1,4,0)
 ;;=4^788.31
 ;;^UTILITY(U,$J,358.3,27899,1,5,0)
 ;;=5^Urinary Incontinence, Urge
 ;;^UTILITY(U,$J,358.3,27899,2)
 ;;=^260046
 ;;^UTILITY(U,$J,358.3,27900,0)
 ;;=788.20^^162^1789^61
 ;;^UTILITY(U,$J,358.3,27900,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27900,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,27900,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,27900,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,27901,0)
 ;;=112.2^^162^1789^63
 ;;^UTILITY(U,$J,358.3,27901,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27901,1,4,0)
 ;;=4^112.2
 ;;^UTILITY(U,$J,358.3,27901,1,5,0)
 ;;=5^Urogenital Candidiasis
 ;;^UTILITY(U,$J,358.3,27901,2)
 ;;=^266866
 ;;^UTILITY(U,$J,358.3,27902,0)
 ;;=600.01^^162^1789^3
 ;;^UTILITY(U,$J,358.3,27902,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27902,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,27902,1,5,0)
 ;;=5^BPH w/ Obstruction
 ;;^UTILITY(U,$J,358.3,27902,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,27903,0)
 ;;=600.10^^162^1789^37
 ;;^UTILITY(U,$J,358.3,27903,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27903,1,4,0)
 ;;=4^600.10
 ;;^UTILITY(U,$J,358.3,27903,1,5,0)
 ;;=5^Nod Prostate w/o Ur Obst
 ;;^UTILITY(U,$J,358.3,27903,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,27904,0)
 ;;=585.9^^162^1789^49
 ;;^UTILITY(U,$J,358.3,27904,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27904,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,27904,1,5,0)
 ;;=5^Renal Failure,Chronic
 ;;^UTILITY(U,$J,358.3,27904,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,27905,0)
 ;;=600.00^^162^1789^4
 ;;^UTILITY(U,$J,358.3,27905,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27905,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,27905,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,27905,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,27906,0)
 ;;=599.70^^162^1789^15
 ;;^UTILITY(U,$J,358.3,27906,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27906,1,4,0)
 ;;=4^599.70
 ;;^UTILITY(U,$J,358.3,27906,1,5,0)
 ;;=5^Hematuria NOS
 ;;^UTILITY(U,$J,358.3,27906,2)
 ;;=^336751
 ;;^UTILITY(U,$J,358.3,27907,0)
 ;;=599.71^^162^1789^16
 ;;^UTILITY(U,$J,358.3,27907,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27907,1,4,0)
 ;;=4^599.71
 ;;^UTILITY(U,$J,358.3,27907,1,5,0)
 ;;=5^Hematuria, Gross
 ;;^UTILITY(U,$J,358.3,27907,2)
 ;;=^336611
 ;;^UTILITY(U,$J,358.3,27908,0)
 ;;=599.72^^162^1789^17
 ;;^UTILITY(U,$J,358.3,27908,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27908,1,4,0)
 ;;=4^599.72
 ;;^UTILITY(U,$J,358.3,27908,1,5,0)
 ;;=5^Hematuria, Microscopic
 ;;^UTILITY(U,$J,358.3,27908,2)
 ;;=^336612
 ;;^UTILITY(U,$J,358.3,27909,0)
 ;;=788.91^^162^1789^58
 ;;^UTILITY(U,$J,358.3,27909,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27909,1,4,0)
 ;;=4^788.91
 ;;^UTILITY(U,$J,358.3,27909,1,5,0)
 ;;=5^Urinary Incontinence, Functional
 ;;^UTILITY(U,$J,358.3,27909,2)
 ;;=^336673
 ;;^UTILITY(U,$J,358.3,27910,0)
 ;;=596.81^^162^1789^31
 ;;^UTILITY(U,$J,358.3,27910,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27910,1,4,0)
 ;;=4^596.81
 ;;^UTILITY(U,$J,358.3,27910,1,5,0)
 ;;=5^Infection of Cystostomy
 ;;^UTILITY(U,$J,358.3,27910,2)
 ;;=^340556
 ;;^UTILITY(U,$J,358.3,27911,0)
 ;;=596.82^^162^1789^33
 ;;^UTILITY(U,$J,358.3,27911,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI1KN
